Apixaban halved the risk for bleeding compared with rivaroxaban in the treatment of acute venous thromboembolism in the ...
Every detail matters. In healthcare, small actions can lead to big outcomes—and sometimes, those outcomes save lives. An often-overlooked threat in outpatient care is Venous Thromboembolism (VTE), ...
MedPage Today on MSN
In Spine Surgery, Blood Thinners May Hurt More Than They Help
Single-center study finds no thrombosis prevention and more complications ...
The majority of fatal cases of pulmonary embolism in hospitalized patients occur in acutely ill, medically treated patients. Current guidelines, based on a large number of prospective, randomized, ...
Effect of a Community Health Worker–Led Intervention Among Low-Income and Minoritized Patients With Cancer: A Randomized Clinical Trial More than 90% of patients in each group were treated with ...
Direct oral anticoagulants (DOACs) have transformed venous thromboembolism (VTE) treatment by offering predictable pharmacokinetics and eliminating routine monitoring requirements. Despite robust ...
Provider Recommendations for Phase I Clinical Trials Within a Shared Decision-Making Model in Phase I Cancer Clinical Trial Discussions Venous Thromboembolism Prevention in the Ambulatory Cancer ...
September 23, 2011 (London, United Kingdom) — Advisors for the European Medicines Agency (EMA) have paved the way for two new indications for rivaroxaban (Xarelto, Bayer) in Europe. The EMA's ...
This the first study to evaluate the risk for venous thromboembolism by lupus nephritis class, according to investigators. Venous thromboembolism (VTE) among patients with lupus nephritis (LN) is not ...
Please provide your email address to receive an email when new articles are posted on . In patients with rheumatoid arthritis, risk of venous thromboembolism was higher in those taking 10 mg of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results